Infantile hemangiomas screening modalities for primary care physicians

نویسندگان

چکیده

Infantile hemangiomas are the most common benign vascular tumors in children. They present a characteristic natural history of spontaneous involution after phase initial proliferation. A small but significant minority demonstrates incomplete regression or complications and requires prompt intervention. Prediction evolution infantile is challenging because their morphological behavioral heterogeneity. The decision between referral for treatment observation sometimes difficult, especially among non-expert physicians, with risk missing period optimizing outcomes case delayed aim this review to update our knowledge, primary care providers, regarding ongoing difficulties early clinical evaluation hemangiomas, outline importance current practical scoring tools identification lesions which require expert consultation referral.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Propranolol for Infantile Hemangiomas

Hemangiomas are common vascular birthmarks that usually present a predictable pattern of proliferation and ultimate involution. Most do not require any treatment. When intervention is clinically indicated, medical and surgical options exist. Historically, corticosteroids have been used and have been shown to slow or stop the growth of a majority of hemangiomas; however, growth concerns and infe...

متن کامل

Primary care physicians' use of screening echocardiography.

OBJECTIVE To survey primary care physicians to understand their reasons for using echocardiography to screen for congenital heart disease in children and to assess their understanding of the costs associated with cardiology services. DESIGN A questionnaire. PARTICIPANTS Eight hundred sixty-seven pediatricians and family physicians in our region were surveyed, 494 (57%) responded and 466 wer...

متن کامل

Novel treatment for infantile hemangiomas.

Evidence Oral propranolol • In an RCT (40 children, aged 9 weeks to 5 years, followed for 6 months),1 2 mg/kg of propranolol (divided 3 times daily) stopped IH growth by week 4 for all children and reduced IH volume at all weeks compared with placebo (eg, -48.5% vs 17.9% in week 12, P = .03). No significant hypotension, hypoglycemia, or bradycardia were reported. • In a systematic review of 40 ...

متن کامل

Infantile hemangiomas: new frontiers.

Guest Editorial I t is a very exciting time for clini-cians who are confronted with infantile hemangiomas. So much new information is now available regarding pathogenesis, epidemiology, differential diagnosis, and therapy. These aspects are reviewed in greater detail in the accompanying articles by a group of experienced scientists and clinicians, who help provide a richer and more sophisticate...

متن کامل

Topical propranolol therapy for infantile hemangiomas.

The nonselective beta-adrenergic receptor antagonist propranolol is an effective therapy for infantile hemangiomas. Systemic propranolol therapy shows a rapid therapeutic effect with good drug tolerability. We report on the efficacy of local application of propranolol ointment in superficial hemangiomas of the skin. In our outpatient department, 45 children with 65 hemangiomas were treated with...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Pediatric investigation

سال: 2023

ISSN: ['2574-2272', '2096-3726']

DOI: https://doi.org/10.1002/ped4.12383